Newcastle University is a member of the Russell Group of leading UK world-class research-intensive universities. The Faculty of Medical Sciences at Newcastle has a particularly strong track-record and reputation for research excellence in the field of Liver Disease, furthering research addressing this major societal challenge. Basic and translational research into MASLD has been a priority area for the Newcastle Liver Group for over 20 years. Members of the group are internationally recognised experts in their respective fields with strong track records for successfully translating basic scientific study of the liver ‘to the bedside’ for patient benefit.
Role in the project
Participant in WP 4, leadership of the European SLD (NAFLD) Registry cohort study.
